Back to search

Article

TK216 targets microtubules in Ewing sarcoma cells

2021-11-19

Abstract excerpt

<h4>ABSTRACT</h4> Ewing sarcoma (EWS) is a pediatric malignancy driven by the EWSR1-FLI1 fusion protein formed by the chromosomal translocation t(11;22). The small molecule TK216 was developed as a first-in-class direct EWSR1-FLI1 inhibitor and is in phase II clinical trials in combination with vincristine for EWS patients. However, TK216 exhibits anti-cancer activity against cancer cell lines and xenografts that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22ff73e5-07ec-53e7-a958-5e9bc270aa6b
DOI
10.1101/2021.11.19.469182
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TK216 targets microtubules in Ewing sarcoma cellsDOI 10.1101/2021.11.19.469182
Select a neighboring publication to make it the new centre.